Back
to List/Filter
Trial Acronym
TBBO8520-101
Registration Number
NCT06343402
Scientific Title
A Phase 1a/1b Open-Label Study of BBO-8520 Monotherapy and BBO-8520 in Combination With Pembrolizumab in Subjects With Advanced KRASG12C Mutant Non-Small Cell Lung Cancer - the ONKORAS-101 Study
Brief Summary
Key Inclusion Criteria
Key Exclusion Criteria
Trial Locations
Primary Sponsor
A first in human study to evaluate the safety, tolerability, and pharmacokinetics (PK) of BBO-8520, a KRAS G12C (ON) inhibitor, single agent and in combination with pembrolizumab in patients with advanced non-small cell lung cancer
Histologically documented locally advanced or metastatic non-small cell lung cancer with a KRAS G12C mutation Measurable disease by RECIST v1.1 Eastern Cooperative Oncology Group (ECOG) performance status (PS) 0-1
Patients with malignancy within the last 2 years as specified in the protocol Patients with untreated brain metastases Patients with known hypersensitivity to BBO-8520 or its excipients For Cohorts 2a and 2b: Patients with a known hypersensitivity to pembrolizumab or its excipients Patients with active autoimmune disease of history of autoimmune disease that might recur Patients with a history of interstitial lung disease/pneumonitis that required steroids, or current interstitial lung disease/pneumonitis
Trial Location Name
Address
Status
The Queen Elizabeth Hospital (Haematology and Oncology)
28 Woodville Rd, Woodville South SA 5011, Australia
Recruiting
Primary Contact :
Pamela Cooper,
Pamela.cooper@sa.gov.au
, 08 8222 6410
Secondary Contact :
Tamara Olszowka,
Tamara.Olszowka@sa.gov.au
, 08 8222 8011
The Ras, Inc
Website URL
Link Name
Link URL
ClinicalTrials.gov
https://clinicaltrials.gov/study/NCT06343402?term=TBBO8520-101&limit=10&rank=1
Secondary IDs
N/A
Study Type
Interventional
Intervention Code
Treatment - Drugs
Phase
Phase 1
Minimum Age
18
Maximum Age
100
Date Registered
11/09/2024
Date Closed
N/A
Status
Open
Enrolment Type
By Specialist and/or Surgeon Referral,Primary Care or GP Referral
Mutation Status and Biomarker
N/A
Is it a Cohort Trial?
No
Is this a Tele-Trial?
No
Can healthy volunteer participate?
No
Discipline
Health Condition
Category
Sub Category
Oncology
Lung
Non Small Cell Lung Cancer
Other
Trial ID
24090032